Evidence map›Paper›PMID 36016378›Full record

ArticleViruses2022

Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment.

Nina Urke Ertesvåg, Sunniva Todnem Sakkestad, Fan Zhou, Ingrid Hoff, Trygve Kristiansen, Trygve Müller Jonassen, Elisabeth Follesø, Karl Albert Brokstad, Ruben Dyrhovden, Kristin G-I Mohn

Open access · goldAbstract readCase Reports
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nina Urke ErtesvågInfluenza Centre, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.ORCID 0000-0001-5243-9101
Sunniva Todnem SakkestadDepartment of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Fan ZhouInfluenza Centre, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.ORCID 0000-0001-9918-3422
Ingrid HoffDepartment of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Trygve KristiansenDepartment of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Trygve Müller JonassenDepartment of Thoracic Medicine, Haukeland University Hospital, 5021 Bergen, Norway.ORCID 0000-0001-5955-9544
Elisabeth FollesøRadiology Department, Haukeland University Hospital, 5021 Bergen, Norway.
Karl Albert BrokstadInfluenza Centre, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.ORCID 0000-0003-0593-2731
Ruben DyrhovdenDepartment of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Kristin G-I MohnInfluenza Centre, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.ORCID 0000-0002-3249-1719
Haukeland University Hospital · NOUniversity of Bergen · NOWestern Norway University of Applied Sciences · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 Drug TreatmentAntibodies, ViralAntiviral AgentsCOVID-19 TestingHumansPolymerase Chain ReactionRituximabSARS-CoV-2Antibodies, ViralAntiviral AgentsRituximabantiviralsB cell immune responseshospitalizedhuman long-term infectionimmunocompromisedlow-grade viral replicationmonoclonal antibodiespersistent feverrituximabSARS-CoV-2

Identifiers

PMID36016378
PMCPMC9414720
OpenAlexW4291670004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.